Loading people...
Geraldine Paulus is a Senior Associate at MPM Capital, a leading venture capital firm specializing in life sciences investments. She plays a key role in identifying, evaluating, and supporting innovative biotech and healthcare companies.
As a Senior Associate at MPM Capital, Geraldine Paulus focuses on investments within the life sciences sector. This includes companies developing novel therapies in areas such as oncology, rare diseases, neuroscience, immunology, and other groundbreaking biotech and healthcare innovations.
Geraldine Paulus works at MPM Capital, a prominent venture capital firm dedicated to advancing life sciences through strategic investments.
Geraldine Paulus is an Investor and Principal at Engine Ventures, an early-stage venture capital firm originally built by the Massachusetts Institute of Technology, based in the Greater Boston Area. She previously served as a Senior Associate at MPM Capital, where she identified and evaluated investment opportunities across innovative biotechnology and advanced technology companies. Paulus holds a Ph.D. in Chemical Engineering from MIT and a Master of Science in Chemical Engineering from KU Leuven, where she published academic research focused specifically on nanomaterials and chemical processes. In her current capacity, she leverages her extensive technical expertise to evaluate complex scientific startups operating within the deep tech, climate tech, and hard tech sectors. Her professional focus centers on bridging the gap between academic scientific innovation and early-stage venture funding to successfully commercialize advanced materials and hardware.
Geraldine Paulus holds the pivotal position of Senior Associate at MPM Capital, a globally recognized venture capital firm at the forefront of life sciences investment. In this crucial role, Geraldine is instrumental in identifying, evaluating, and supporting the next generation of groundbreaking biotech and healthcare companies. Her work directly contributes to MPM Capital's mission of investing in innovative science that promises to deliver transformative medical solutions to patients worldwide.
MPM Capital has a long-standing reputation for its deep expertise in the life sciences sector, focusing on areas such as novel drug discovery, platform technologies, oncology, rare diseases, neuroscience, and immunology. As a Senior Associate, Geraldine Paulus is deeply embedded in the firm's investment process, from initial market analysis to post-investment portfolio support. Her responsibilities typically include comprehensive market research to identify emerging trends and unmet medical needs, rigorous scientific and commercial due diligence on potential investment targets, and financial modeling to assess viability and potential returns.
Individuals in Geraldine's role at a leading life sciences venture capital firm like MPM Capital often possess a unique blend of scientific acumen and business insight. While specific details of her career background are not publicly available, it is common for Senior Associates in this field to have a strong foundation in biological sciences, medicine, or related disciplines, coupled with experience in finance, consulting, or industry roles within the healthcare ecosystem. This multidisciplinary expertise enables Geraldine to critically evaluate complex scientific data, understand clinical development pathways, and assess the commercial potential of novel therapeutic approaches.
Geraldine Paulus's investment focus areas align closely with MPM Capital's strategic priorities, encompassing companies developing cutting-edge therapies in high-impact disease areas. She plays a vital part in sourcing new opportunities, engaging with entrepreneurs and scientific founders, and presenting compelling investment cases to the broader investment committee. Her analytical skills and industry insights are invaluable in navigating the intricate landscape of biotech innovation, helping to pinpoint companies with the potential to significantly impact patient care.
Through her dedication and expertise, Geraldine Paulus helps to drive MPM Capital's commitment to fostering innovation. She supports portfolio companies in their growth trajectories, providing strategic guidance and monitoring their progress towards key milestones. Her contributions are essential in MPM Capital's efforts to translate pioneering scientific discoveries into successful companies that bring life-changing medicines and technologies to those who need them most. Geraldine Paulus is a key contributor to the future of life sciences investment.
